Exactech Inc. (EXAC) Issues Q3 Earnings Guidance
Exactech Inc. (NASDAQ:EXAC) updated its third quarter earnings guidance on Monday. The company provided EPS guidance of $0.24-0.26 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.25, Analyst Ratings.Net reports. The company issued revenue guidance of $57.5-59.5 million, compared to the consensus revenue estimate of $58.64 million.Exactech also updated its FY14 guidance to $1.19-1.23 EPS.
Exactech Inc. (NASDAQ:EXAC) opened at 22.78 on Tuesday. Exactech Inc. has a 52 week low of $18.34 and a 52 week high of $26.52. The stock has a 50-day moving average of $24.62 and a 200-day moving average of $23.28. The company has a market cap of $311.1 million and a price-to-earnings ratio of 19.69.
Exactech (NASDAQ:EXAC) last posted its quarterly earnings results on Monday, July 28th. The company reported $0.30 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $0.30. The company had revenue of $63.92 million for the quarter, compared to the consensus estimate of $63.80 million. During the same quarter in the prior year, the company posted $0.27 earnings per share. The company’s quarterly revenue was up 5.4% on a year-over-year basis. Analysts expect that Exactech Inc. will post $1.21 EPS for the current fiscal year.
Exactech, Inc develops, manufactures and sells orthopedic implant devices, related surgical instruments and biological material and services to make patients more mobile.
Receive News & Ratings for Exactech Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exactech Inc and related companies with Analyst Ratings Network's FREE daily email newsletter.